BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6124052)

  • 1. [Antihypertensive effect of betaxolol at increasing doses].
    Pathe M; Steimer C; Schwartz J
    Therapie; 1982; 37(1):75-82. PubMed ID: 6124052
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of betaxolol (Kerlone) as a once-daily treatment for hypertension in 4685 patients.
    Djian J
    Br J Clin Pract; 1985 May; 39(5):188-91. PubMed ID: 2866790
    [No Abstract]   [Full Text] [Related]  

  • 3. [Betaxolol versus nifedipine in the treatment of essential hypertension].
    Steiner A; Hany S; Bättig B; Jenni R; Troesch M; Willimann P; Graf A; Leutenegger F; Angehrn V; Beck G
    Schweiz Rundsch Med Prax; 1988 Oct; 77(41):1101-3. PubMed ID: 2907178
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in hemodynamics and renal function during the oral administration of betaxolol].
    Pathe M; Schwartz J
    Therapie; 1985; 40(4):209-12. PubMed ID: 2862715
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dose-response study of betaxolol in arterial hypertension].
    Pathe M; Steimer C; Cazor JL; Schwartz J
    Therapie; 1983; 38(2):143-8. PubMed ID: 6356451
    [No Abstract]   [Full Text] [Related]  

  • 6. [The antihypertensive effect of a new beta-adrenergic blocking drug metroprolol in combination with chlorthalidone].
    Jäättelä A; Pyöräiä K
    Duodecim; 1976; 92(11):597-603. PubMed ID: 7445
    [No Abstract]   [Full Text] [Related]  

  • 7. [Beta-adrenergic hypertonia in psychosomatic manifestations of anxiety and the therapeutic effect of a cardioselective beta-blockader: betaxolol].
    Le Van D; Mayeux D; Kohler C; Regnier F; Coquelin JP; Grilliat JP
    Therapie; 1988; 43(6):451-6. PubMed ID: 2906488
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intraindividual comparison of 2 bisoprolol dosages in patients with essential hypertension].
    Cardona R; Disselhoff G; Lizarraga P; Orozco M; Perez-Acuna F; Monsalve P; Vera O; Lopez B; Schmidt-Dommerque F; Tremarias A
    Med Klin (Munich); 1986 Apr; 81(9):307-10. PubMed ID: 2878358
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.
    Hansson L; Henningsen NC; Karlberg B; Aberg H; Jameson S; Malmcrona R; Hersvall C
    Int J Clin Pharmacol; 1974 Oct; 10(3):206-11. PubMed ID: 4154313
    [No Abstract]   [Full Text] [Related]  

  • 10. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation.
    Jackson DA
    Br J Clin Pract; 1980 Jul; 34(7):211-21. PubMed ID: 6107120
    [No Abstract]   [Full Text] [Related]  

  • 11. Tobanum treatment in mild and medium severity hypertension.
    Udvarhelyi A
    Ther Hung; 1986; 34(3):171-4. PubMed ID: 2894722
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of arotinolol hydrochloride on hemodynamics, catecholamine levels and metabolism in patients with essential hypertension].
    Morimoto Y; Kasai A; Nagano K; Umino M; Kakuta Y; Iwata J; Konishi T; Hamada M; Nakano T
    Kokyu To Junkan; 1988 Mar; 36(3):311-5. PubMed ID: 2453908
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of betaxolol on ventricular arrhythmias. Control of efficacy and tolerance by repetitive Holter recordings].
    Fillette F; Lebrun S; Malkawi K
    Ann Cardiol Angeiol (Paris); 1985 Jun; 34(6):409-12. PubMed ID: 2862835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of Cordanum in labile hypertension].
    Gerasimiuk PP; Zaporozhets TF; Slobodianik GP
    Vrach Delo; 1982 Nov; (11):29-30. PubMed ID: 6130655
    [No Abstract]   [Full Text] [Related]  

  • 15. Medium-term effects of betaxolol monotherapy and combination therapy with nitrendipine on lipoprotein and apolipoprotein metabolism in patients with mild to moderate essential hypertension.
    Saku K; Zhang B; Okamoto T; Takeda Y; Liu K; Jimi S; Arakawa K
    J Hum Hypertens; 1996 Apr; 10(4):263-8. PubMed ID: 8736459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acute and chronic effects of betaxolol on blood pressure, renin-aldosterone, and renal function in essential hypertension.
    Reams GP; Bauer JH; Lau A
    J Clin Pharmacol; 1987 Feb; 27(2):118-21. PubMed ID: 2890665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of a new beta-adrenergic receptor blocking substance, indenolol].
    Cirino D; Savonelli C; Maggi GC
    Minerva Cardioangiol; 1983 Nov; 31(11):671-6. PubMed ID: 6142433
    [No Abstract]   [Full Text] [Related]  

  • 18. [Double-blind study of betaxolol in patients with acute myocardial infarction].
    Yang XS
    Zhonghua Nei Ke Za Zhi; 1985 Dec; 24(12):712-4, 767. PubMed ID: 2869922
    [No Abstract]   [Full Text] [Related]  

  • 19. [Betaxolol. A new beta blockader with beta-1-selectivity in glaucoma treatment].
    Thygesen J
    Ugeskr Laeger; 1988 Mar; 150(12):755-8. PubMed ID: 2896406
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficacy of the nadolol-bendroflumethiazide combination in the treatment of arterial hypertension].
    Zecchi P; Bellocci F; Santarelli P; Iannarelli M
    Clin Ter; 1986 Jan; 116(1):19-24. PubMed ID: 2870837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.